HH
BMY icon

Hilltop Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Hilltop Holdings’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,000
Closed -$382K – 386
2019
Q1 		$382K Buy
+8,000
New +$399K 0.08% 240

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hilltop Holdings's BMY Position: Q1 2026 in Review

Hilltop Holdings reduced its Bristol-Myers Squibb (BMY) stake by 53% in Q1 2026, selling an estimated $1.68M and leaving 25,193 shares worth $1.53M. The position accounts for 0.14% of the portfolio, ranked #168.

Hilltop Holdings first reported a position in BMY in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.92M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Hilltop Holdings held 25,193 shares of Bristol-Myers Squibb worth $1.53M as of Q1 2026.
  • Hilltop Holdings sold 28,810 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.68M.
  • Bristol-Myers Squibb made up 0.14% of Hilltop Holdings's portfolio in Q1 2026, its #168 holding.
  • Hilltop Holdings first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 49 quarters since.
  • Hilltop Holdings's Bristol-Myers Squibb position peaked at $2.92M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.